Christopher James Stevens serves as Executive at ROCKET PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Christopher James Stevens has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 4, 2025 involved receiving (via award) 407,166 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 4, 2025 | RCKT | $0 | Award | 407,166 | $N/A | Discretionary |
Christopher James Stevens currently holds 407,166 shares of ROCKET PHARMACEUTICALS, INC. (RCKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher James Stevens has been a net neutral trader of RCKT stock. They have purchased $0 and sold $0 worth of shares.
Christopher James Stevens's most recent insider trade was on Aug 4, 2025, when they sold 407,166 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted